Revolutionizing Safe & Potent Activation of TLR, STING & Other Innate Immunity Sensors to Target Solid Tumors, Optimize Clinical Approach & Supercharge Your Pipeline

Welcome to the STING & TLR-Targeting Therapies Summit

Plus Innate Immune Checkpoints & Activation Pre-Conference Focus Day

The STING & TLR-Targeting Therapies Summit is coming at a timely inflection point in this field.

With multiple TLR agonists moving into the clinic, STING agonists exposing new challenges, multiple approvals on the horizon, and more novel targets and combinations currently undergoing exciting pre-clinical validation than ever before, this unique and highly anticipated industry-focused meeting will unite experts in innate immunity to overcome the barriers it faces and accelerate clinical breakthrough.

Returning in-person to the biopharma hub of Boston, 30+ expert speakers will take you through case-study led presentations, juicy panel discussions and live Q&A’s, all tailored to suit your TLR, STING & other PRR targeting needs.

This is the key in-person biopharma conference for research teams
developing drug candidates targeting any specific PRR targets (TLRs,
cGAS/STING, NLRs, CLRs, RLRs) to revolutionize treatment options for patients.

If you are striving to create best-in-class innate immunity
therapeutics, don’t miss this unique and highly anticipated industry-focused meeting uniting world-experts in innate immunity to propel this space through the barriers it faces to clinical breakthrough.

View the event guide now for the full agenda.

150+ Reasons to Join in 2022:

  • 100+ key decision makers from across the TLR, PRR & innate immune landscape
  • 30+ industry expert speakers providing you with the latest and greatest insights from this field
  • 20+ hours of content exploring the latest preclinical & clinical advancements to help optimize your approaches and advance your pipeline
  • 4+ hours of dedicated networking time to make new connections, ask your questions and benchmark against your industry
  • 1 pre-conference focus day deep diving into innate subsets during checkpoint blockade to develop combination therapies
Health & Safety
The health, safety and well-being of our community remains our highest priority, therefore, all attendees will be required to complete a health declaration prior to attending the event, as well as comply with the City of Boston’s B Together policy. This policy requires individuals to show you proof of vaccination against COVID-19 in order to gain admittance to the conference venue. For further information around Health and Safety onsite, please visit our FAQs page here or for more information on the B Together Policy, please see here.
*Please note, this is subject to change at any time without prior notice.

2022 Speakers Include:

What Will You Learn?

STING & TLR Favicon

Clinical progress with innate immune-targeting compounds

STING & TLR Favicon

Rationale & progress in targeting different TLRs

STING & TLR Favicon

The development of predictive preclinical models in PRR research to achieve human-specific translation

STING & TLR Favicon

The emerging targets in PRR-targeting: strategy, execution, development & promise

STING & TLR Favicon

How to optimize clinical trial design for innate immunotherapy drug development

STING & TLR Favicon

How to optimize your PRR-based drug delivery technology

STING & TLR Favicon

How to analyze & optimize the various drug format options

STING & TLR Favicon

The next steps in PRR combination interventions to heighten drug effect & overcome resistance - is this the future?

Innate Immune Checkpoints & Activation Pre-Focus Day

The dedicated focus day will delve into identifying the role of innate subsets during checkpoint blockade to develop combination therapies and help overcome checkpoint resistance through:

  • Delving into honing of innate cells
  • Nw methodologies of analyzing innate immune cells in the tumor microenvironment
  • Exploring reprograming of the tumor micoenvironment
  • Optimizing in vitro models and discovery technologies for innate cell-based therapies
  • Uncovering novel checkpoint inhibitors
  • Gaining updates on
    clinical trials for
    immunotherapies

Who Attended in 2021?

Team Discounts Available!

Attend as a team to make the most of this huge learning & networking opportunity and to unlock discounted passes for your organization:

  • 3 Passes - 10% Discount
  • 4 Passes - 15% Discount
  • 5+ Passes - 20% Discount

Your team discount will be applied automatically when you purchase 3 or more passes online.

For assistance, please contact the team here and we'll be happy to help.

Proud to Partner With:

The health, safety and well-being of our community remains our highest priority. Therefore, all attendees will be required to complete a health declaration prior to attending the event. As part of this, attendees must declare that they are either fully vaccinated and /or have completed a negative Lateral Flow Test or PCR Test within 48 hours the event*. For further information around Health and Safety onsite, please visit our FAQ here.

*Please note, this is subject to change at any time without prior notice.